Induction of early neural precursors and derivation of tripotent neural stem cells from human pluripotent stem cells under xeno-free conditions

Journal of Comparative Neurology

Volumn 522, Issue 12, 2014, Pages 2767-2783

  Nguyen, Hal X ^a   Nekanti, Usha ^a   Haus, Daniel L ^a   Funes, Gabrielle ^a   Moreno, Denisse ^a   Kamei, Noriko ^a   Cummings, Brian J ^a   Anderson, Aileen J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hESC; hiPSC; Human neural stem cells; Neuralization; Oligoprogenitors; Xeno free

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; LEUKEMIA INHIBITORY FACTOR; COMPOMER; CYCLINE; HOMEODOMAIN PROTEIN; MKI67IP PROTEIN, HUMAN; NANOG PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; SIGNAL PEPTIDE; XENO COMPOMER;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ADHESION; CELL FATE; CELL LINEAGE; CELL PROLIFERATION; CELL REGENERATION; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; EMBRYO; EMBRYONIC STEM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KARYOTYPE; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NEURAL STEM CELL; NEURALIZED SPHERE; NONHUMAN; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; TRIPOTENT NEURAL STEM CELL; XENO-FREE CULTURE; CELL DIFFERENTIATION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY;

CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPOMERS; EMBRYONIC STEM CELLS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KARYOTYPE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; OLIGODENDROGLIA; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 84912047915     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23604     Document Type: Article

References (47)

1. Allegrucci C, Young LE. 2007. Differences between human embryonic stem cell lines. Hum Reprod Update 13:103-120.
2. Asheuer M, Pflumio F, Benhamida S, Dubart-Kupperschmitt A, Fouquet F, Imai Y, Aubourg P, Cartier N. 2004. Human CD341 cells differentiate into microglia and express recombinant therapeutic protein. Proc Natl Acad Sci U S A101:3557-3562.
3. Bergstrom R, Strom S, Holm F, Feki A, Hovatta O. 2011. Xeno-free culture of human pluripotent stem cells. Methods Mol Biol 767:125-136.
4. Bilic J, Izpisua Belmonte JC. 2012. Concise review: induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells 30:33-41.
5. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. 2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27:275-280.
6. Chera B, Schaecher KE, Rocchini A, Imam SZ, Ray SK, Ali SF, Banik NL. 2002. Calpain upregulation and neuron death in spinal cord of MPTP-induced parkinsonism in mice. Ann N Y Acad Sci 965:274-280.
7. Chiba S, Lee YM, Zhou W, Freed CR. 2008. Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats. Stem Cells 26:2810-2820.
8. Cobo F, Stacey GN, Hunt C, Cabrera C, Nieto A, Montes R, Cortes JL, Catalina P, Barnie A, Concha A. 2005. Microbiological control in stem cell banks: approaches to standardisation. Appl Microbiol Biotechnol 68:456-466.
9. Denham M, Dottori M. 2009. Signals involved in neural differentiation of human embryonic stem cells. Neurosignals 17:234-241.
10. Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN. 2009. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277-280.
11. Ebert AD, Shelley BC, Hurley AM, Onorati M, Castiglioni V, Patitucci TN, Svendsen SP, Mattis VB, McGivern JV, Schwab AJ, et al. 2013. EZ spheres: a stable and expandable culture system for the generation of prerosette multipotent stem cells from human ESCs and iPSCs. Stem Cell Res 10:417-427.
12. Erceg S, Lainez S, Ronaghi M, Stojkovic P, Perez-Arago MA, Moreno-Manzano V, Moreno-Palanques R, Planells-Cases R, Stojkovic M. 2008. Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions. PLoS One 3:e2122.
13. Erceg S, Ronaghi M, Oria M, Rosello MG, Arago MA, Lopez MG, Radojevic I, Moreno-Manzano V, Rodriguez-Jimenez FJ, Bhattacharya SS, et al. 2013. Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells 28:1541-1549.
14. Findikli N, Kahraman S, Akcin O, Sertyel S, Candan Z. 2005. Establishment and characterization of new human embryonic stem cell lines. Reprod Biomed Online 10:617-627.
15. Goolsby J, Marty MC, Heletz D, Chiappelli J, Tashko G, Yarnell D, Fishman PS, Dhib-Jalbut S, Bever CT Jr, Pessac B, Trisler D. 2003. Hematopoietic progenitors express neural genes. Proc Natl Acad Sci U S A100:14926-14931.
16. Guillaume DJ, Zhang SC. 2008. Human embryonic stem cells: a potential source of transplantable neural progenitor cells. Neurosurg Focus 24:E3.
17. Hatch MN, Nistor G, Keirstead HS. 2009. Derivation of highpurity oligodendroglial progenitors. Methods Mol Biol 549:59-75.
18. Jackman N, Ishii A, Bansal R. 2009. Oligodendrocyte development and myelin biogenesis: parsing out the roles of glycosphingolipids. Physiology (Bethesda)24:290-297.
19. Jouhilahti EM, Peltonen S, Peltonen J. 2008. Class III betatubulin is a component of the mitotic spindle in multiple cell types. J Histochem Cytochem 56:1113-1119.
20. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91:461-553.
21. Kohen NT, Little LE, Healy KE. 2009. Characterization of Matrigel interfaces during defined human embryonic stem cell culture. Biointerphases 4:69-79.
22. Lee G, Kim H, Elkabetz Y, Al Shamy G, Panagiotakos G, Barberi T, Tabar V, Studer L. 2007. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol 25:1468-1475.
23. Leroy K, Duyckaerts C, Bovekamp L, Muller O, Anderton BH, Brion JP. 2001. Increase of adenomatous polyposis coli immunoreactivity is a marker of reactive astrocytes in Alzheimer's disease and in other pathological conditions. Acta Neuropathol 102:1-10.
24. Li XJ, Du ZW, Zarnowska ED, Pankratz M, Hansen LO, Pearce RA, Zhang SC. 2005. Specification of motoneurons from human embryonic stem cells. Nat Biotechnol 23:215-221.
25. Martin MJ, Muotri A, Gage F, Varki A. 2005. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11:228-232.
26. McClain CR, Sim FJ, Goldman SA. 2012. Pleiotrophin suppression of receptor protein tyrosine phosphatase-beta/zeta maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells. J Neurosci 32:15066-15075.
27. Nagaoka M, Si-Tayeb K, Akaike T, Duncan SA. 2010. Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum. BMC Dev Biol 10:60.
28. Nguyen HX, Tidball JG. 2003. Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro. J Physiol 547:125-132.
29. Nishiyama A, Komitova M, Suzuki R, Zhu X. 2009. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 10:9-22.
30. Okamura RM, Lebkowski J, Au M, Priest CA, Denham J, Majumdar AS. 2007. Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells. J Neuroimmunol 192:134-144.
31. Okuno T, Nakayama T, Konishi N, Michibata H, Wakimoto K, Suzuki Y, Nito S, Inaba T, Nakano I, Muramatsu S, et al. 2009. Self-contained induction of neurons from human embryonic stem cells. PLoS One 4:e6318.
32. Pomp O, Brokhman I, Ben-Dor I, Reubinoff B, Goldstein RS. 2005. Generation of peripheral sensory and sympathetic neurons and neural crest cells from human embryonic stem cells. Stem Cells 23:923-930.
33. Rada-Iglesias A, Wysocka J. 2011. Epigenomics of human embryonic stem cells and induced pluripotent stem cells: insights into pluripotency and implications for disease. Genome Med 3:36.
34. Rajala K, Lindroos B, Hussein SM, Lappalainen RS, Pekkanen-Mattila M, Inzunza J, Rozell B, Miettinen S, Narkilahti S, Kerkela E, et al. 2010. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One 5:e10246.
35. Sareen D, McMillan E, Ebert AD, Shelley BC, Johnson JA, Meisner LF, Svendsen CN. 2009. Chromosome 7 and 19 trisomy in cultured human neural progenitor cells. PLoS One 4:e7630.
36. Sartore RC, Campos PB, Trujillo CA, Ramalho BL, Negraes PD, Paulsen BS, Meletti T, Costa ES, Chicaybam L, Bonamino MH, et al. 2011. Retinoic acid-treated pluripotent stem cells undergoing neurogenesis present increased aneuploidy and micronuclei formation. PLoS One 6:e20667.
37. Schwartz CM, Tavakoli T, Jamias C, Park SS, Maudsley S, Martin B, Phillips TM, Yao PJ, Itoh K, Ma W, et al. Stromal factors SDF1alpha, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells. J Neurosci Res 90:1367-1381.
38. Shyu WC, Lin SZ, Chiang MF, Su CY, Li H. 2006. Intracerebral peripheral blood stem cell (CD341) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci 26:3444-3453.
39. Skottman H, Hovatta O. 2006. Culture conditions for human embryonic stem cells. Reproduction 132:691-698.
40. Sundberg M, Hyysalo A, Skottman H, Shin S, Vemuri M, Suuronen R, Narkilahti S. 2011. A xeno-free culturing protocol for pluripotent stem cell-derived oligodendrocyte precursor cell production. Regen Med 6:449-460.
41. Swistowski A, Zeng X. 2012. Scalable Production of Transplantable Dopaminergic Neurons from hESCs and iPSCs in Xeno-Free Defined Conditions. Curr Protoc Stem Cell Biol Chapter 2, Unit2D 12.
42. Swistowski A, Peng J, Han Y, Swistowska AM, Rao MS, Zeng X. 2009. Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS One 4: e6233.
43. Wada T, Honda M, Minami I, Tooi N, Amagai Y, Nakatsuji N, Aiba K. 2009. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS One 4:e6722.
44. Xue Y, Cai X, Wang L, Liao B, Zhang H, Shan Y, Chen Q, Zhou T, Li X, Hou J, et al. 2013. Generating a non-integrating human induced pluripotent stem cell bank from urinederived cells. PLoS One 8:e70573.
45. Zangiacomi V, Balon N, Maddens S, Lapierre V, Tiberghien P, Schlichter R, Versaux-Botteri C, Deschaseaux F. 2008. Cord blood-derived neurons are originated from CD1331/CD34 stem/progenitor cells in a cell-to-cell contact dependent manner. Stem Cells Dev 17:1005-1016.
46. Zhang XQ, Zhang SC. 2010. Differentiation of neural precursors and dopaminergic neurons from human embryonic stem cells. Methods Mol Biol 584:355-366.
47. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. 2001. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19:1129-1133.